Aion Therapeutic Inc. (CSE: AION)

Aion Therapeutic Income Statement

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 31, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019
Cost of Revenue	0.06	-	-	0	-	-
Gross Profit	0.16	-	-	-0	-	-
Selling, General & Admin	0.98	0.84	1.37	2	0.85	0.92
Research & Development	-	-	0.95	-	-	0.02
Operating Expenses	0.99	0.86	2.39	2.6	0.96	1.49
Operating Income	-0.83	-0.86	-2.39	-2.6	-0.96	-1.49
Interest Expense	-0.15	-0.15	-0.08	-0.19	-0.32	-0.68
Earnings From Equity Investments	-0.11	-0.11	-	-	-	-
Currency Exchange Gain (Loss)	0	0.17	0.08	-0.17	-	-
Other Non Operating Income (Expenses)	-0.02	-0.12	-0.43	-0.17	-0.03	-0.16
EBT Excluding Unusual Items	-1.1	-1.07	-2.82	-3.13	-1.32	-2.33
Impairment of Goodwill	-	-	-	-2.54	-	-
Asset Writedown	-	0.25	-1	-2.6	-	-
Other Unusual Items	-	0.56	-	-	0.65	-2.6
Pretax Income	-1.1	-0.26	-3.82	-8.27	-0.67	-4.93
Net Income	-1.1	-0.26	-3.82	-8.27	-0.67	-4.93
Net Income to Common	-1.1	-0.26	-3.82	-8.27	-0.67	-4.93
Shares Outstanding (Basic)	200	146	140	94	36	27
Shares Outstanding (Diluted)	200	146	140	94	36	27
Shares Change (YoY)	38.05%	4.65%	48.98%	161.64%	30.62%	212.46%
EPS (Basic)	-0.01	-0.00	-0.03	-0.09	-0.02	-0.18
EPS (Diluted)	-0.01	-0.00	-0.03	-0.09	-0.02	-0.18
Free Cash Flow	0.12	-0.04	-1.35	-2.13	-0.76	-3.27
Free Cash Flow Per Share	0.00	-0.00	-0.01	-0.02	-0.02	-0.12
EBITDA	-0.83	-0.84	-2.33	-2.47	-0.85	-
D&A For EBITDA	0	0.02	0.07	0.13	0.11	-
EBIT	-0.83	-0.86	-2.39	-2.6	-0.96	-1.49
Advertising Expenses	-	-	-	-	-	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.